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ABSTRACT
Objective: Huntington's Disease is a progressive 
degenerative disorder having an expanded triplicate 
repeat in the gene IT-15 on chromosome 4. The 
interrelation between the trinucleotide repeat length 
and disease progression was studied.
Methods: Five patients included in the study were 
evaluated by "Quantified staging of functional capacity 
for Huntington's Disease patients” and age of disease 
onsets were determined. Progression rate was 
calculated and interrelationship between age of 
disease onset and repeat length; progression rate and 
repeat length were studied.
Results: We found a statistically significant negative 
correlation between age of disease onset and 
trinucleotide repeat length (pearson r=-0.9514 
p<0.05). There was a statistically significant positive 
correlation between CAG repeat length and 
progression rate (pearson r=0.8809, p<0.05).
Conclusion: Our study, conducted with a very limited 
number of patients, revealed the correlation between 
trinucleotide repeat length and disease progression. 
It like few similar studies in the literature, gave an 
impression of the important pathophysiological role of 
expanded CAG repeat during the entire course of the 
disease.
Key W ords: Huntington's Disease, progression 
rate, trinucleotide repeat, prognosis.
INTRODUCTION
Huntington's Disease (HD) is a dominantly inherited 
neurodegenerative disorder usually presenting in adult 
life with progressive chorea, affective disorder and
dementia (1 ). The genetic defect causing HD has been 
mapped to the short arm of chromosome 4 (2). In 
1993, gene IT-15 containing a highly polymorphic CAG 
repeat in the 5' region, which is expanded and 
unstable in HD, was described (3).
The discovery of the genetic mutation for HD allows 
the examination of the relationship between the 
etiology of the disease and its clinical characteristics. 
The number of repeats on normal chromosomes 
ranges from 12-31. On HD chromosomes it ranges 
from 37-80. Because the number of trinucleotide 
repeat varies among patients, we are able to 
determine the correlation between inter-individual 
variability in clinical presentation and rate of 
progression. Past studies revealed a significant 
negative correlation between the repeat lengths and 
the age of disease onset (4,5). However the 
significance of the expanded triplet repeat for the rate 
of clinical progression is not clear (6 ). A detailed 
analysis of the correlation of disease progression rate 
with CAG repeat expansion may bring new insights 
into the mechanisms of the pathophysiology of HD.
Here we report the results of our investigation on the 
HD patients in the Turkish population. We reported the 
correlation between the ages of disease onset, 
disease progression rate and CAG repeat expansion 
of HD patients followed by our movement disorder 
clinic.
PATIENTS AND METHODS
Five patients with positive family history for HD and 
abnormal CAG repeat size were studied. For each 
patient, the age of HD onset was determined by asking 
the patient and multiple unaffected family members to 
recollect the first occurrance of chorea, rigidity, 
irritability, sleep disturbance, frequent falls, altered
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sexual behaviour, altered social behaviour or falling 
memory. Patients were assessed by "Quantified 
Staging of Functional Capacity for HD Patients" (7). 
We calculated the progression rate by dividing disease 
duration (year) with the functional capacity score of the 
patient.
Statistics: Age of disease onset and trinucleotide 
repeat length; progression rate and trinucleotide 
repeat length were studied statistically by Pearson 
correlation and regression analysis.
progression of both neurologic and psychiatric 
features in 20 HD patients from Russia. In 1996, 
Brandt et al (8 ) studied the largest series to date of 
genetically tested 46 patients prospectively at regular 
intervals. In this report, patients in the long repeat 
length group were significantly younger at disease 
onset and there was a significant inverse correlation 
between repeat lengths and onset age. In the aspect 
of disease progression, they showed that patients with 
long repeat lengths showed more rapid decline in both 
the neurologic and cognitive measures of disease 
severity over a two-year follow-up period.
RESULTS
Three of the patients were women, two were men. 
Mean age of disease onset was 38.8+11.25 (25-54). 
The mean progression rate was 1.658±1.992 (0.3-5) 
and the mean CAG repeat length was 46.6±6.656 (40- 
55). We found a statistically significant negative 
correlation between the age of disease onset and 
trinucleotide repeat length (pearson r= -0.9514 
p<0.05). There was a statistically significant positive 
correlation between CAG repeat length and 
progression rate (pearson r=0.8809, p<0.05). Between 
the age of disease onset and progression rate, we 
found a tendency for negative correlation not showing 
statistical difference (pearson r= -0.8298 p=0.0821). 
Detailed information about the cases is shown in 
table I.
Table I. Data of the patients included in the study Progression 
rate was calculated by dlvldln disease duration (year) to 
functions capacity score of the patient.
case 1 case 2 case 3 case 4 case 5
Age of disease onset 54 25 45 38 32
Disease duration (yr) 4 5 2 2 8
Family history Paternal Metarnal Maternal Maternal Paternal
Progression rate 0.3 5 0.63 0.36 2
CAG repeat length 40 55 41 45 52
DISCUSSION
In our study, there was a significant negative 
correlation between CAG repeat length and age of 
disease onset. The progression rate correlated 
positively with trinucleotide repeat length, like in 
lllarioshkin (6 ) and Brandt's (8 ) studies. Therefore one 
may conclude that the degree of repeat elongation not 
only affects the beginning of the disease, but also, 
more interestingly it is relevant to the tempo of loss of 
normal function in HD patients.
lllarioshkin et al (6 ) recognized the significance of the 
repeat expansion which was more evident for larger 
expansions associated with more rapid progression of 
the disease. They suggested a "treshold" for 
accelerated progression with repeats longer then 52. 
In the light of this knowledge, our case 2 (table I) with 
55 CAG repeat length had the severest progression 
rate supporting the lllarioshkin’s study results.
Our study, including very limited number of patients, 
revealed the correlation between trinucleotide repeat 
length and disease progression. A large sample 
containing studies with a more comprehensive 
neuropsychological battery is needed to evaluate the 
Turkish population. In 1998 Apaydin et al (9) reported 
3 genetically diagnosed Hungtington’s disease 
patients with clinical and radiological findings. For the 
Turkish population, follow-up results will be more 
valuable to ascertain the disease progression and 
trinucleotide repeat length interrelationship, as in 
Brandt's (8 ) study. In conclusion, our study gave an 
impression of the important pathophysiological role of 
expanded CAG repeat during the entire course of the 
disease.
Previous studies of CAG repeat expansion in HD 
patients revealed a strong association between the 
repeat lengths and the ages of disease onset (4,5). 
These data provided the moleculer basis for the 
phenomenon of anticipation (6 ). However these 
studies shed little light on the significance of CAG 
repeat lengths for the course of the disease, 
lllarioshkin et al (6 ) recently reported significant 
correlations between CAG repeat length and rate of
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